Atlas Trials

Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease

Clinical trial NCT07242222 · RECRUITING

Trial details

NCT number
NCT07242222
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fatty Liver
Start date
2025-11-20
Primary completion
2026-11-20
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.